Market Overview

Trade AMED stock with recommended broker Ally Invest. Commissions as low as $3.95.

Analyst Rating View All Ratings

DateResearch FirmActionCurrentTarget
12/14/18BarclaysInitiates Coverage OnEqual-Weight130.0
11/16/18UBSInitiates Coverage OnNeutral126.0
10/30/18BenchmarkUpgradesHoldBuy0.0
Show more Loading articles...

Earnings View Earnings

Q3 2018 EST Actual Surprise
EPS: 0.77 0.95 0.18
Rev: 411.20M 417.34M 6.14M
Q4 2018 EST Actual Surprise
EPS: Expected
2019-02-26
Rev:

Company Profile